| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.35 | 5e-10 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.31 | 8e-08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.2 | 0.0007 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.13 | 0.03 |